ToxGenSolutions

ToxGenSolutions is a company that develops diagnostic tools aimed at enhancing preclinical diagnostics for Alzheimer's Disease. The organization utilizes (epi-)genetic methods to investigate molecular initiation events and key factors in adverse outcome pathways related to various pathologies, including neurodegeneration, cancer, and immune dysfunction. By focusing on mechanism-based genetic signatures, ToxGenSolutions assists in identifying and classifying new leads and toxicants during the screening, product development, and safety assessment phases of drug development. This approach enables healthcare professionals to intervene early in disease progression, improving the potential for effective treatment and prevention.